报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 3.16% | -55.68% | -15.05% | 84/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | 3.72% | -31.62% | 110.17% | 55/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | 1.77% | -42.53% | -74.42% | 69/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | 6.92% | -19.72% | -2.95% | 49/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | 7.13% | -8.71% | 31.07% | 45/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | 5.44% | -1.27% | 76.62% | 36/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | 3.08% | 6.94% | -64.27% | 34/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | 8.62% | 4.87% | 10.37% | 52/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | 7.81% | 37.02% | 41.74% | 47/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | 5.51% | 19.78% | 91.32% | 44/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | 2.88% | 17.55% | -64.96% | 42/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | 8.22% | -37.68% | 44.21% | 56/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
2021-09-30 | 5.7% | -54.73% | 23.91% | 72/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
2021-06-30 | 4.6% | -29.66% | 87.76% | 61/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
2021-03-31 | 2.45% | -42.22% | -81.43% | 56/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
2020-12-31 | 13.19% | 18.08% | 4.77% | 38/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
2020-09-30 | 12.59% | 29.13% | 92.51% | 25/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
2020-06-30 | 6.54% | 3.15% | 54.25% | 41/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
2020-03-31 | 4.24% | 18.11% | -62.04% | 19/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
2019-12-31 | 11.17% | -36.53% | 14.56% | 51/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
2019-09-30 | 9.75% | -49.59% | 53.79% | 37/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
2019-06-30 | 6.34% | -60.15% | 76.6% | 35/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
2019-03-31 | 3.59% | 2% | -79.6% | 27/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
2018-12-31 | 17.6% | -34.3% | -9% | 26/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
2018-09-30 | 19.34% | 2% | 21.56% | 3/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
2018-06-30 | 15.91% | 2% | -40.61% | 1/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
2017-12-31 | 26.79% | 4.24% | 4.24% | 4/160 | 9.66% | 昂利康 | 15.91% | 行业排名> |
2016-12-31 | 25.7% | -2.87% | -2.87% | 8/160 | 6.33% | 奥赛康 | 12.08% | 行业排名> |
2015-12-31 | 26.46% | 16.1% | 16.1% | 13/160 | 11.35% | 一品红 | 31.62% | 行业排名> |